IRulya Therapeutics (IRLA) Shares Outstanding (Diluted) (2021 - 2026)
IRulya Therapeutics' Weighted Average Shares Outstanding (Diluted) came in at 6.13 million for Q2 2026, compared with 233,431 a year earlier.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
For FY2025, IRulya Therapeutics' Weighted Average Shares Outstanding (Diluted) was 250,484, up 15.8% from FY2024.
- Weighted Average Shares Outstanding (Diluted) has increased in each of the last four years, with a four-year compound annual growth rate of 13.9% (FY2021 to FY2025).
- Going back by year, Weighted Average Shares Outstanding (Diluted) was 216,311 in FY2024 (+16.2%), 186,186 in FY2023 (+11.2%), 167,483 in FY2022 (+12.7%) and 148,593 in FY2021.
- The Q2 2026 figure represents the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q2 2021.
- Across the past five years, year-over-year growth in Weighted Average Shares Outstanding (Diluted) ran from 1.3% in Q3 2023 to 109.2% in Q1 2026.
- Business Quant data shows IRLA's Weighted Average Shares Outstanding (Diluted) at 459,518 (Q1 2026), 250,484 (Q4 2025) and 269,757 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 5.75 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | 6.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.13 Mn |
| Mar 31, 2026 | 459,518.00 |
| Dec 31, 2025 | 250,484.00 |
| Sep 30, 2025 | 269,757.00 |
| Jun 30, 2025 | 233,431.00 |
| Mar 31, 2025 | 219,706.00 |
| Dec 31, 2024 | 216,311.00 |
| Sep 30, 2024 | 215,821.00 |
| Jun 30, 2024 | 215,482.00 |
| Mar 31, 2024 | 215,051.00 |
| Dec 31, 2023 | 186,186.00 |
| Sep 30, 2023 | 180,365.00 |
| Jun 30, 2023 | 179,588.00 |
| Mar 31, 2023 | 179,276.00 |
| Dec 31, 2022 | 167,483.00 |
| Sep 30, 2022 | 178,064.00 |
| Jun 30, 2022 | 162,335.00 |
| Mar 31, 2022 | 150,672.00 |
| Dec 31, 2021 | 148,593.00 |
| Sep 30, 2021 | 148,837.00 |
API Access
IRulya Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();